Boen L.R. Kam
- Epidemiology top 0.5%
- Oncology top 0.5%
- Neurology top 0.2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Endocrinology, Diabetes and Metabolism top 2%
- Co-authors
- Dik J. KwekkeboomWouter W. de HerderEric P. KrenningJaap J.M. TeunissenCasper H.J. van EijckMartijn van EssenRichard A. FeeldersP.P.M. Kooij
- Topics
- Neuroendocrine Tumor Research Advances (31 papers)Lung Cancer Research Studies (27 papers)Neuroblastoma Research and Treatments (21 papers)
- Cited by
- NeurologyOncologyEpidemiology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Boen L.R. Kam
47 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Epidemiology 3.6k
- Oncology 3.2k
- Neurology 2.6k
- Radiology, Nuclear Medicine and Imaging 1.2k
- Endocrinology, Diabetes and Metabolism 465
Countries citing papers authored by Boen L.R. Kam
This map shows the geographic impact of Boen L.R. Kam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boen L.R. Kam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boen L.R. Kam more than expected).
Fields of papers citing papers by Boen L.R. Kam
This network shows the impact of papers produced by Boen L.R. Kam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boen L.R. Kam. The network helps show where Boen L.R. Kam may publish in the future.
Co-authorship network of co-authors of Boen L.R. Kam
This figure shows the co-authorship network connecting the top 25 collaborators of Boen L.R. Kam. A scholar is included among the top collaborators of Boen L.R. Kam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boen L.R. Kam. Boen L.R. Kam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 41 | |
| 3 | 36 | |
| 4 | A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine | 3 |
| 5 | 99 | |
| 6 | 29 | |
| 7 | Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumorsbreakdown → | 416 |
| 8 | 5 | |
| 9 | 47 | |
| 10 | 126 | |
| 11 | 23 | |
| 12 | 22 | |
| 13 | 38 | |
| 14 | 58 | |
| 15 | 181 | |
| 16 | 132 | |
| 17 | 112 | |
| 18 | 122 | |
| 19 | Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survivalbreakdown → | 1093 |
| 20 | 328 |
About Boen L.R. Kam
Boen L.R. Kam is a scholar working on Neurology, Oncology and Epidemiology, having authored 47 papers that have together received 4.7k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (31 papers), Lung Cancer Research Studies (27 papers) and Neuroblastoma Research and Treatments (21 papers). The work is most often cited by research in Neurology (2.6k citations), Oncology (3.2k citations) and Epidemiology (3.6k citations). Boen L.R. Kam has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Dik J. Kwekkeboom, Wouter W. de Herder, Eric P. Krenning, Jaap J.M. Teunissen, Casper H.J. van Eijck, Martijn van Essen, Richard A. Feelders, P.P.M. Kooij, Maarten O. van Aken and Marion de Jong. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.